Arch Plast Surg. 2012 Sep;39(5):504-8. doi: 10.5999/aps.2012.39.5.504. Epub 2012 Sep 12.
Does fibrin sealant reduce seroma after immediate breast reconstruction utilizing a latissimus dorsi myocutaneous flap?.
Archives of plastic surgery
Han Gyu Cha, Sang Gue Kang, Ho Seong Shin, Moon Seok Kang, Seung Min Nam
Affiliations
Affiliations
- Department of Plastic and Reconstructive Surgery, Soonchunhyang University College of Medicine, Seoul, Korea.
PMID: 23094246
PMCID: PMC3474408 DOI: 10.5999/aps.2012.39.5.504
Abstract
BACKGROUND: The most common complication of latissimus dorsi myocutaneous flap in breast reconstruction is seroma formation in the back. Many clinical studies have shown that fibrin sealant reduces seroma formation. We investigated any statistically significant differences in postoperative drainage and seroma formation when utilizing the fibrin sealant on the site of the latissimus dorsi myocutaneous flap harvested for immediate breast reconstruction after skin-sparing partial mastectomy.
METHODS: A total of 46 patients underwent immediate breast reconstruction utilizing a latissimus dorsi myocutaneous island flap. Of those, 23 patients underwent the procedure without fibrin sealant and the other 23 were administered the fibrin sealant. All flaps were elevated with manual dissection by the same surgeon and were analyzed to evaluate the potential benefits of the fibrin sealant. The correlation analysis and Mann-Whitney U test were used for analyzing the drainage volume according to age, weight of the breast specimen, and body mass index.
RESULTS: Although not statistically significant, the cumulative drainage fluid volume was higher in the control group until postoperative day 2 (530.1 mL compared to 502.3 mL), but the fibrin sealant group showed more drainage beginning on postoperative day 3. The donor site comparisons showed the fibrin sealant group had more drainage beginning on postoperative day 3 and the drain was removed 1 day earlier in the control group.
CONCLUSIONS: The use of fibrin sealant resulted in no reduction of seroma formation. Because the benefits of the fibrin sealant are not clear, the use of fibrin sealant must be fully discussed with patients before its use as a part of informed consent.
Keywords: Fibrin tissue adhesive; Mastectomy; Seroma
References
- Clin Plast Surg. 1984 Apr;11(2):343-50 - PubMed
- Plast Reconstr Surg. 1990 May;85(5):826 - PubMed
- Eur Surg Res. 1995;27(5):346-52 - PubMed
- Plast Reconstr Surg. 2010 May;125(5):1309-1317 - PubMed
- Plast Reconstr Surg. 1994 Nov;94(6):881-4 - PubMed
- Ann Plast Surg. 1996 Oct;37(4):400-5 - PubMed
- Am Surg. 1993 Apr;59(4):215-8 - PubMed
- Plast Reconstr Surg. 1997 Mar;99(3):842-9; discussion 850-1 - PubMed
- G Chir. 1993 Apr-May;14(4-5):239-41 - PubMed
- Vox Sang. 1997;72(3):133-43 - PubMed
- Plast Reconstr Surg. 1996 Jun;97(7):1443-50 - PubMed
- Thromb Haemost. 1995 Jul;74(1):482-5 - PubMed
- Clin Otolaryngol Allied Sci. 1992 Dec;17(6):487-90 - PubMed
- Eur Surg Res. 1998;30(6):439-43 - PubMed
Publication Types